Sangamo Therapeutics France SAS - ESG Rating & Company Profile powered by AI
Detailed Sustainability assessment of Sangamo Therapeutics France SAS are reached by registering for free. This report of Sangamo Therapeutics France SAS was assembled by All Street Sevva using advanced NLP. The webpage contains a zero-cost E,S&G report covering Sangamo Therapeutics France SAS.
Sangamo Therapeutics France SAS in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 5.3, social score of 3.2 and governance score of 6.0.
4.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Analytik Jena AG | 8.0 | High |
1 | Amniotics AB (publ) | 8.0 | High |
65 | Alpha Cognition Inc | 4.9 | High |
65 | Sunzen Biotech Bhd | 4.9 | High |
70 | Sangamo Therapeutics France SAS | 4.8 | High |
70 | Amryt Pharmaceuticals Inc | 4.8 | High |
72 | Covance Inc | 4.6 | High |
... | ... | ... | |
182 | Wesana Health Holdings Inc | 0.0 | Low |
182 | rEVO Biologics Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sangamo Therapeutics France SAS have an accelerator or VC vehicle to help deliver innovation?
Does Sangamo Therapeutics France SAS disclose current and historical energy intensity?
Does Sangamo Therapeutics France SAS report the average age of the workforce?
Does Sangamo Therapeutics France SAS reference operational or capital allocation in relation to climate change?
Does Sangamo Therapeutics France SAS disclose its ethnicity pay gap?
Does Sangamo Therapeutics France SAS disclose cybersecurity risks?
Does Sangamo Therapeutics France SAS offer flexible work?
Does Sangamo Therapeutics France SAS have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sangamo Therapeutics France SAS disclose the number of employees in R&D functions?
Does Sangamo Therapeutics France SAS conduct supply chain audits?
Does Sangamo Therapeutics France SAS disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sangamo Therapeutics France SAS conduct 360 degree staff reviews?
Does Sangamo Therapeutics France SAS disclose the individual responsible for D&I?
Does Sangamo Therapeutics France SAS disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sangamo Therapeutics France SAS disclose current and / or historical scope 2 emissions?
Does Sangamo Therapeutics France SAS disclose water use targets?
Does Sangamo Therapeutics France SAS have careers partnerships with academic institutions?
Did Sangamo Therapeutics France SAS have a product recall in the last two years?
Does Sangamo Therapeutics France SAS disclose incidents of discrimination?
Does Sangamo Therapeutics France SAS allow for Work Councils/Collective Agreements to be formed?
Has Sangamo Therapeutics France SAS issued a profit warning in the past 24 months?
Does Sangamo Therapeutics France SAS disclose parental leave metrics?
Does Sangamo Therapeutics France SAS disclose climate scenario or pathway analysis?
Does Sangamo Therapeutics France SAS disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sangamo Therapeutics France SAS disclose the pay ratio of women to men?
Does Sangamo Therapeutics France SAS support suppliers with sustainability related research and development?
Does Sangamo Therapeutics France SAS disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sangamo Therapeutics France SAS reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sangamo Therapeutics France SAS involved in embryonic stem cell research?
Does Sangamo Therapeutics France SAS disclose GHG and Air Emissions intensity?
Does Sangamo Therapeutics France SAS disclose its waste policy?
Does Sangamo Therapeutics France SAS report according to TCFD requirements?
Does Sangamo Therapeutics France SAS disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sangamo Therapeutics France SAS disclose energy use targets?
Does Sangamo Therapeutics France SAS disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sangamo Therapeutics France SAS have a policy relating to cyber security?
Have a different question?
Potential Risks for Sangamo Therapeutics France SAS
These potential risks are based on the size, segment and geographies of the company.